Zora Pharma Ltd - Stock Valuation and Financial Performance

Name: Zora Pharma
Brand: Zora Pharma

BSE: 524438 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Zora Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

Zora Pharma stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

1.5 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Zora Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05	TTM
ROCE % ⓘ	14.3%	12.9%	-39.7%	-39.5%	-7.1%	-10.9%	-13.8%	-15.5%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	16.2	15.6	7.2	1.7	0.5	0.3	0	0	0
Sales YoY Gr.	-	-3.5%	-53.8%	-75.9%	-73%	-40.4%	-89.3%	-100%	-
Adj EPS ⓘ	1	0.5	-10.7	-10.1	-4.1	-4.5	-4.6	-4.5	-1.2
YoY Gr.	-	-53.6%	-2484.4%	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	14.2	14.5	-1.4	-12.2	-16.2	-20.5	-25	-29.6	-4.2
Adj Net Profit ⓘ	0.6	0.3	-6.7	-6.3	-2.6	-2.8	-2.9	-2.8	-1
Cash Flow from Ops. ⓘ	1.9	0.7	-1.8	-2.3	-3	-2.9	-0.3	-0.3	-
Debt/CF from Ops. ⓘ	5.1	14.8	-5.3	-6.8	-5.8	-6.7	-62.8	-75.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-100%	-100%	-100%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	NA	NA	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05	TTM
Return on Equity % ⓘ	6.6	3.1	-244.5	148.9	29.5	24.4	20.1	16.6	7.2
Op. Profit Mgn % ⓘ	21.2	22.7	-41.4	-171.8	-181.6	-151.9	-1228.5	-69179.8	-359.5
Net Profit Mgn % ⓘ	3.7	1.8	-92.7	-361.8	-543.9	-973.8	-9483.6	-743551.1	-1887.6
Debt to Equity ⓘ	1.1	1.2	-10.4	-2.1	-1.7	-1.5	-1.4	-1.3	-
Working Cap Days ⓘ	0	229	250	735	1,868	2,667	20,733	14,97,531	0
Cash Conv. Cycle ⓘ	0	115	133	202	202	454	10,638	8,00,596	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Zora Pharma Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-1.2	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	-4.2	-
Reserves (₹ Cr.) ⓘ	-9	-
P/BV ⓘ	-0.57	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	1.20 / 12.85
Market Cap (₹ Cr.)	1.5
Equity (₹ Cr.)	6.2
Face Value (₹)	10
Industry PE ⓘ	44.4

Management X-Ray of Zora Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Zora Pharma

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Zora Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Sales	16.21	15.64	10.84	1.74	0.47	0.28	0.03	0
Operating Expenses ⓘ	12.78	12.13	15.57	4.89	1.33	0.73	0.40	0.26
Manufacturing Costs	2.70	2.26	2.20	0.42	0.41	0.12	0.07	0.07
Material Costs	8.45	8.09	10.96	3.83	0.49	0.27	0.09	0
Employee Cost	0.71	0.76	0.98	0.16	0.18	0.08	0.09	0.10
Other Costs ⓘ	0.92	1.03	1.42	0.48	0.25	0.26	0.15	0.10
Operating Profit ⓘ	3.44	3.51	-4.73	-3.15	-0.86	-0.44	-0.37	-0.26
Operating Profit Margin (%)	21.2%	22.4%	-43.7%	-181.0%	-181.0%	-155.0%	-1,228.5%	-69,179.8%
Other Income ⓘ	0.44	0.41	0.43	0.24	1.33	0.59	0.32	0.16
Interest ⓘ	1.88	2.13	3.85	2.30	2.02	2	1.96	1.95
Depreciation ⓘ	1.25	1.48	2.05	1.18	1.03	0.93	0.84	0.77
Exceptional Items ⓘ	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.75	0.31	-10.20	-6.39	-2.57	-2.78	-2.85	-2.82
Tax ⓘ	0.05	0.03	0	0	0	0	0	0
Profit After Tax	0.70	0.27	-10.20	-6.39	-2.57	-2.78	-2.85	-2.83
PAT Margin (%)	4.3%	1.7%	-94.2%	-367.0%	-543.0%	-976.0%	-9,468.9%	-7,43,551.1%
Adjusted EPS (₹)	1.1	0.4	-16.4	-10.2	-4.1	-4.5	-4.6	-4.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Equity and Liabilities
Shareholders Fund	9.08	9.25	-1.03	-7.42	-9.98	-12.77	-15.61	-18.44
Share Capital ⓘ	6.24	6.24	6.24	6.24	6.24	6.24	6.24	6.24
Reserves ⓘ	2.83	3	-7.28	-13.66	-16.23	-19.01	-21.86	-24.68
Minority Interest	0	0	0	0	0	0	0	0
Debt	9.52	10.40	13.87	15.79	17.48	19.65	21.61	23.70
Long Term Debt	9.52	10.40	13.87	15.79	17.48	19.65	21.61	23.70
Short Term Debt	0	0	0	0	0	0	0	0
Trade Payables	2.90	2.89	5.14	5.67	5.23	4.17	3.90	3.81
Others Liabilities ⓘ	2.54	2.92	0.58	0.58	0.57	0.57	0.57	0.57
Total Liabilities ⓘ	24.04	25.46	18.56	14.62	13.30	11.63	10.47	9.65
Fixed Assets
Gross Block	17.50	19.73	18.96	17.83	17.88	17.83	17.73	17.73
Accumulated Depreciation	4.11	5.50	7.27	7.65	8.68	9.58	10.32	11.09
Net Fixed Assetsⓘ	13.39	14.22	11.69	10.18	9.20	8.25	7.41	6.64
CWIP ⓘ	0.37	0	1.14	1.14	1.14	1.14	1.14	1.14
Investmentsⓘ	0.04	0.04	0	0	0	0	0	0
Inventories	6.43	6.71	3.37	1	0.54	0.35	0.28	0.28
Trade Receivables	2.14	2.85	0.84	0.83	1.08	0.77	0.57	0.54
Cash Equivalents	0.45	0.46	0.44	0.46	0.44	0.37	0.34	0.32
Others Assetsⓘ	1.22	1.18	1.09	1.02	0.90	0.74	0.72	0.73
Total Assets ⓘ	24.04	25.46	18.56	14.62	13.30	11.63	10.47	9.65

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Cash Flow From Operating Activity ⓘ	1.87	0.71	-2.64	-2.32	-3.02	-2.92	-0.34	-0.31
PBT ⓘ	0.70	0.27	-10.28	-6.39	-2.57	-2.78	-2.85	-2.83
Adjustment ⓘ	2.80	3.34	5.90	3.54	1.80	2.43	2.50	2.56
Changes in Working Capital ⓘ	0.28	-0.63	5.62	2.82	-0.23	-0.56	0	-0.05
Tax Paid ⓘ	-0.02	-0.15	-0.03	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	-3.89	-1.52	-0.67	0.44	1.28	0.60	0.32	0.16
Capex	-4.33	-1.93	-0.89	0.19	-0.05	0.01	0.01	0
Net Investments	0.02	0	0.04	0.03	0	0	0	0
Others ⓘ	0.42	0.41	0.17	0.21	1.33	0.59	0.31	0.16
Cash Flow From Financing Activityⓘ	2.04	0.82	3.29	1.90	1.71	2.25	-0.01	0.13
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	-0.52	0	0	0	0	0	0	0
Others ⓘ	2.56	0.82	3.29	1.90	1.71	2.25	-0.01	0.13
Net Cash Flow ⓘ	0.02	0	-0.02	0.03	-0.02	-0.07	-0.03	-0.03

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Ratios
ROE (%)	7.9	3.06	N/A	N/A	N/A	N/A	N/A	N/A
ROCE (%)	14.32	12.87	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover Ratio	0.7	0.65	0.52	0.11	0.04	0.02	0	0
PAT to CFO Conversion(x)	2.67	2.63	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	47	57	59	161	707	1,164	8,161	0
Inventory Days	140	150	162	420	567	559	3,866	0
Payable Days	125	131	134	516	4,048	6,395	0	0

Zora Pharma Ltd Stock News

Zora Pharma Ltd FAQs

What is the share price of Zora Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Zora Pharma on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Zora Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Zora Pharma stood at ₹1.47.

What is the P/E ratio of Zora Pharma?

The latest P/E ratio of Zora Pharma as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Zora Pharma?

The latest P/B ratio of Zora Pharma as of 01-Jan-1970 05:30 is -0.57.

What is the 52-week high and low of Zora Pharma?

The 52-week high of Zora Pharma is ₹0.00 and the 52-week low is ₹0.00.

What is the TTM revenue of Zora Pharma?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zora Pharma is ₹0.04 ( Cr.) .

About Zora Pharma Ltd

Zora Pharma Ltd was incorporated as a private limited company registered with the Registrar of Companies, Gujarat vide Certificate of Incorporation dated February 21, 1985 and was subsequently converted into a Public Limited Company vide special resolution passed on 9th July, 1993. The Company was promoted by the Patankar family in 1985 and since 1986 has been engaged in the manufacture of TMP, a bulk drug. The company is situated at 604, Aniket C.G. ROAD, Navarangpura Ahmedabad, Gujarat, India.

In the beginning it started manufacturing & marketing Trimethodprim an antibacterial bulk drug, by importing the major intermediate 3,4,5 Trimethoxybenzaldehyde. In view of problems faced by Comp. is getting imported intermediate in time & increase in cost due to Exchange Rate Fluctuations etc., the Comp. couldn't perform well till 1991.

The Comp. decided to start manufacturing Trimethoprim from basic stage & successfully developed the process technology for manufacture of 3,4,5 Trimethoxybenezaldehyde from indigenously available raw material in 1991. This was the turning point in the history of Company.

Zora Pharma was amalgamated on 01/01/2010(record date) with Intas Pharmaceuticals Ltd. (an unlisted company) pursuant to the sanctioned Scheme of Rehabilitation by BIFR. Intas Pharmaceuticals Ltd. issued and alloted to the shareholders of Zora Pharma Ltd. in the ratio of 1 (ONE) 5% Redeemable preference share of the face value of Rs10- each (redeemable within 60 months from the date of the sanction of the scheme) of Intas Pharmaceuticals Ltd. for every 48(FORTY EIGHT) Equity Shares of the face value of Rs.10/- each held in Zora Pharma Ltd.